SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 175.48 |
| Enterprise Value ($M) | 259.57 |
| Book Value ($M) | -126.82 |
| Book Value / Share | -4.08 |
| Price / Book | -1.38 |
| NCAV ($M) | -158.09 |
| NCAV / Share | -5.08 |
| Price / NCAV | -1.11 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | 0.05 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.16 |
| Current Ratio | 1.50 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 69.98 |
| Assets | 101.25 |
| Liabilities | 228.08 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Bandera Partners LLC | 7.50 | 32.90 | |
| 13G | BlackRock, Inc. | 5.30 | 0.00 | |
| 13G/A | Roystone Capital Management LP | 6.90 | -23.50 | |
| 13G/A | Boston Partners | 2.45 | -15.85 | |
| 13G/A | LMR Partners LLP | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 29,205 | 99,288 | 29.41 | |
| 12,453 | 63,213 | 19.70 | |
| 19,904 | 69,957 | 28.45 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AXSM – Axsome Therapeutics, Inc. | BCAB – BioAtla, Inc. |
| BHST – BioHarvest Sciences Inc. | CADL – Candel Therapeutics, Inc. |
| CARM – Carisma Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io